DAVID M. REESE - 06 May 2025 Form 4 Insider Report for AMGEN INC (AMGN)

Role
EVP & Chief Technology Officer
Signature
/s/ David M. Reese
Issuer symbol
AMGN
Transactions as of
06 May 2025
Transactions value $
$6,204,975
Form type
4
Filing time
08 May 2025, 20:59:57 UTC
Previous filing
06 May 2025
Next filing
12 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
REESE DAVID M EVP & Chief Technology Officer ONE AMGEN CENTER, DRIVE, THOUSAND OAKS /s/ David M. Reese 07 May 2025 0001748434

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock Award $0 +3.55K +9.2% $0.00 42.1K 06 May 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMGN Nqso (Right to Buy) Award $6.2M +22.9K $270.44 22.9K 06 May 2025 Common Stock 22.9K $270.44 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/6/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2 These shares include 397 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F3 These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/6/2026.